Atavistik Bio
Cambridge, United States· Est. 2021
Atavistik Bio is focused on unlocking hidden functional pockets to discover transformative allosteric precision therapeutics to address serious unmet patient needs.
Private Company
Total funding raised: $100M
About
Atavistik Bio is focused on unlocking hidden functional pockets to discover transformative allosteric precision therapeutics to address serious unmet patient needs.
Small Molecules
Funding History
2Total raised:$100M
Series A$60MMar 15, 2023
Seed$40MOct 15, 2021